These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 25855779)

  • 21. Abnormalities of the PRMT1-ADMA-DDAH1 metabolism axis and probucol treatment in diabetic patients and diabetic rats.
    Mei X; Zeng J; Liu DF; Zhao Y; Yang HL; Li Y; Qiu P; Tang MW
    Ann Palliat Med; 2021 Mar; 10(3):3343-3353. PubMed ID: 33849119
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Active site mutant dimethylarginine dimethylaminohydrolase 1 expression confers an intermediate tumour phenotype in C6 gliomas.
    Boult JK; Walker-Samuel S; Jamin Y; Leiper JM; Whitley GS; Robinson SP
    J Pathol; 2011 Nov; 225(3):344-52. PubMed ID: 21590769
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Overexpression of dimethylarginine dimethylaminohydrolase protects against cerebral vascular effects of hyperhomocysteinemia.
    Rodionov RN; Dayoub H; Lynch CM; Wilson KM; Stevens JW; Murry DJ; Kimoto M; Arning E; Bottiglieri T; Cooke JP; Baumbach GL; Faraci FM; Lentz SR
    Circ Res; 2010 Feb; 106(3):551-8. PubMed ID: 20019334
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Overexpression of dimethylarginine dimethylaminohydrolase 1 protects from angiotensin II-induced cardiac hypertrophy and vascular remodeling.
    Kopaliani I; Jarzebska N; Billoff S; Kolouschek A; Martens-Lobenhoffer J; Bornstein SR; Bode-Böger SM; Ragavan VN; Weiss N; Mangoni AA; Deussen A; Rodionov RN
    Am J Physiol Heart Circ Physiol; 2021 Nov; 321(5):H825-H838. PubMed ID: 34533401
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Asymmetric Dimethylarginine Enables Depolarizing Spikes and Vasospasm in Mesenteric and Coronary Resistance Arteries.
    Ng YYH; Dora KA; Lemmey HAL; Lin J; Alden J; Wallis L; Donovan L; Shorthose O; Leiper FC; Leiper J; Garland CJ
    Hypertension; 2024 Apr; 81(4):764-775. PubMed ID: 38226470
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dimethylarginine dimethylaminohydrolase-2 deficiency promotes vascular regeneration and attenuates pathological angiogenesis.
    Lange C; Mowat F; Sayed H; Mehad M; Duluc L; Piper S; Luhmann U; Nandi M; Kelly P; Smith A; Ali R; Leiper J; Bainbridge J
    Exp Eye Res; 2016 Jun; 147():148-155. PubMed ID: 27181226
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Repetitive ischemia increases myocardial dimethylarginine dimethylaminohydrolase 1 expression.
    Zhang P; Fassett JT; Zhu G; Li J; Hu X; Xu X; Chen Y; Bache RJ
    Vasc Med; 2017 Jun; 22(3):179-188. PubMed ID: 28145161
    [TBL] [Abstract][Full Text] [Related]  

  • 28. DDAH1 deficiency promotes intracellular oxidative stress and cell apoptosis via a miR-21-dependent pathway in mouse embryonic fibroblasts.
    Zhao C; Li T; Han B; Yue W; Shi L; Wang H; Guo Y; Lu Z
    Free Radic Biol Med; 2016 Mar; 92():50-60. PubMed ID: 26806551
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dimethylarginine dimethylaminohydrolase1 is an organ-specific mediator of end organ damage in a murine model of hypertension.
    Sydow K; Schmitz C; von Leitner EC; von Leitner R; Klinke A; Atzler D; Krebs C; Wieboldt H; Ehmke H; Schwedhelm E; Meinertz T; Blankenberg S; Böger RH; Magnus T; Baldus S; Wenzel U
    PLoS One; 2012; 7(10):e48150. PubMed ID: 23110194
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Enhancing kidney DDAH-1 expression by adenovirus delivery reduces ADMA and ameliorates diabetic nephropathy.
    Wetzel MD; Gao T; Stanley K; Cooper TK; Morris SM; Awad AS
    Am J Physiol Renal Physiol; 2020 Feb; 318(2):F509-F517. PubMed ID: 31904280
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Extensive characterization of the human DDAH1 transgenic mice.
    Schwedhelm E; von Leitner EC; Atzler D; Schmitz C; Jacobi J; Meinertz T; Münzel T; Baldus S; Cooke JP; Böger RH; Maas R; Sydow K
    Pharmacol Res; 2009 Dec; 60(6):494-502. PubMed ID: 19666120
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of dimethylarginine dimethylaminohydrolase-1 overexpression on the response of the pulmonary vasculature to hypoxia.
    Bakr A; Pak O; Taye A; Hamada F; Hemeida R; Janssen W; Gierhardt M; Ghofrani HA; Seeger W; Grimminger F; Schermuly RT; Witzenrath M; Brandes RP; Huang N; Cooke JP; Weissmann N; Sommer N
    Am J Respir Cell Mol Biol; 2013 Sep; 49(3):491-500. PubMed ID: 23642043
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dimethylarginine Dimethylaminohydrolase 1 Protects Against High-Fat Diet-Induced Hepatic Steatosis and Insulin Resistance in Mice.
    Li T; Feng R; Zhao C; Wang Y; Wang J; Liu S; Cao J; Wang H; Wang T; Guo Y; Lu Z
    Antioxid Redox Signal; 2017 Apr; 26(11):598-609. PubMed ID: 27565538
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Asymmetric dimethylarginine, endothelial dysfunction and renal disease.
    Aldámiz-Echevarría L; Andrade F
    Int J Mol Sci; 2012; 13(9):11288-11311. PubMed ID: 23109853
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Endothelial Dimethylarginine Dimethylaminohydrolase 1 Is an Important Regulator of Angiogenesis but Does Not Regulate Vascular Reactivity or Hemodynamic Homeostasis.
    Dowsett L; Piper S; Slaviero A; Dufton N; Wang Z; Boruc O; Delahaye M; Colman L; Kalk E; Tomlinson J; Birdsey G; Randi AM; Leiper J
    Circulation; 2015 Jun; 131(25):2217-25. PubMed ID: 25910799
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Asymmetric dimethylarginine (ADMA) as an important risk factor for the increased cardiovascular diseases and heart failure in chronic kidney disease.
    Liu X; Xu X; Shang R; Chen Y
    Nitric Oxide; 2018 Aug; 78():113-120. PubMed ID: 29928990
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Vascular endothelial-specific dimethylarginine dimethylaminohydrolase-1-deficient mice reveal that vascular endothelium plays an important role in removing asymmetric dimethylarginine.
    Hu X; Xu X; Zhu G; Atzler D; Kimoto M; Chen J; Schwedhelm E; Lüneburg N; Böger RH; Zhang P; Chen Y
    Circulation; 2009 Dec; 120(22):2222-9. PubMed ID: 19917889
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Genetic variation in the dimethylarginine dimethylaminohydrolase 1 gene (DDAH1) is related to asymmetric dimethylarginine (ADMA) levels, but not to endothelium-dependent vasodilation.
    Lind L; Ingelsson E; Kumar J; Syvänen AC; Axelsson T; Teerlink T
    Vasc Med; 2013 Aug; 18(4):192-9. PubMed ID: 23892448
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dimethylarginine dimethylaminohydrolase 1 regulates nerve growth factor-promoted differentiation of PC12 cells in a nitric oxide-dependent but asymmetric dimethylargenine-independent manner.
    Wang S; Hu CP; Yuan Q; Zhang WF; Zhou Z; Nie SD; Jiang JL; Li YJ
    J Neurosci Res; 2012 Jun; 90(6):1209-17. PubMed ID: 22488726
    [TBL] [Abstract][Full Text] [Related]  

  • 40. ADMA elevation does not exacerbate development of diabetic nephropathy in mice with streptozotocin-induced diabetes mellitus.
    Rodionov RN; Jarzebska N; Schneider A; Rexin A; Sradnick J; Brilloff S; Martens-Lobenhoffer J; Bode-Böger SM; Todorov V; Hugo C; Weiss N; Hohenstein B
    Atheroscler Suppl; 2019 Dec; 40():100-105. PubMed ID: 31818438
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.